These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25788966)

  • 1. The inhibitory effect of kakkonto, Japanese traditional (kampo) medicine, on brain penetration of oseltamivir carboxylate in mice with reduced blood-brain barrier function.
    Ohara K; Oshima S; Fukuda N; Ochiai Y; Maruyama A; Kanamuro A; Negishi A; Honma S; Ohshima S; Akimoto M; Takenaka S; Kobayashi D
    Evid Based Complement Alternat Med; 2015; 2015():917670. PubMed ID: 25788966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.
    Gibiansky L; Giraudon M; Rayner CR; Brennan BJ; Subramoney V; Robson R; Kamal MA
    J Pharmacokinet Pharmacodyn; 2015 Jun; 42(3):225-36. PubMed ID: 25821064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive amination assistance for quantification of oseltamivir phosphate and oseltamivir carboxylate by HPLC-MS/MS.
    Huang MF; Lin YR; Chang YT; Shiue YL; Liang SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():23-28. PubMed ID: 29702353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
    Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
    Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the interaction of tamiflu and oseltamivir carboxylate with human serum albumin.
    Nafisi S; Vishkaee TS
    J Photochem Photobiol B; 2011 Oct; 105(1):34-9. PubMed ID: 21803598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans.
    Gao G; Law F; Wong RNS; Mak NK; Yang MSM
    ADMET DMPK; 2019; 7(1):22-43. PubMed ID: 35350745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of central nervous system and hypothermic effects after single oral administration of high doses of oseltamivir in the rat.
    Freichel C; Breidenbach A; Hoffmann G; Körner A; Gatti S; Donner B; Bansod S; Bellot M; Gand L; Weiser T; Singer T; Prinssen EP
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):50-7. PubMed ID: 22309322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient Prescriptions of Kampo Formulations in Japan.
    Yamana H; Ono S; Michihata N; Jo T; Yasunaga H
    Intern Med; 2020 Nov; 59(22):2863-2869. PubMed ID: 32713918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maoto, a traditional Japanese medicine, controls acute systemic inflammation induced by polyI:C administration through noradrenergic function.
    Ogura K; Kadota A; Nakayama A; Kanno H; Tahara Y; Nishi A
    Gene; 2022 Jan; 806():145921. PubMed ID: 34454033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Japanese herbal kampo medicine kakkonto with antibiotic use and surgical drainage for noninfectious mastitis: A nationwide database study.
    Endo M; Konishi T; Yamana H; Jo T; Ishikawa T; Yasunaga H
    J Obstet Gynaecol Res; 2024 Jan; 50(1):113-119. PubMed ID: 37844586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice.
    Oshima S; Nemoto E; Kuramochi M; Saitoh Y; Kobayashi D
    J Pharm Pharmacol; 2009 Oct; 61(10):1397-400. PubMed ID: 19814874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution Analysis via Mass Spectrometry Imaging of Ephedrine in the Lungs of Rats Orally Administered the Japanese Kampo Medicine Maoto.
    Matsumoto T; Kushida H; Matsushita S; Oyama Y; Suda T; Watanabe J; Kase Y; Setou M
    Sci Rep; 2017 Mar; 7():44098. PubMed ID: 28272490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population.
    Huang H; Wang J; Li Q; Duan J; Yao Q; Zheng Q; Wang J; Wu D; Zhou Q; Tian Y; Zhang J
    J Matern Fetal Neonatal Med; 2017 Jun; 30(11):1288-1292. PubMed ID: 27426925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database.
    Suzuki S; Obara T; Ishikawa T; Noda A; Matsuzaki F; Arita R; Ohsawa M; Mano N; Kikuchi A; Takayama S; Ishii T
    Front Nutr; 2021; 8():762895. PubMed ID: 34869533
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication
    Nomura T; Fukushi M; Oda K; Higashiura A; Irie T; Sakaguchi T
    Evid Based Complement Alternat Med; 2019; 2019():3230906. PubMed ID: 31871477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in sympathetic nerve activity as a possible mechanism for the hypothermic effect of oseltamivir, an anti-influenza virus drug, in normal mice.
    Ono H; Iwajima Y; Nagano Y; Chazono K; Maeda Y; Ohsawa M; Yamamoto S
    Basic Clin Pharmacol Toxicol; 2013 Jul; 113(1):25-30. PubMed ID: 23398656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviative Effects of a Kampo (a Japanese Herbal) Medicine "Maoto (Ma-Huang-Tang)" on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action.
    Nagai T; Kataoka E; Aoki Y; Hokari R; Kiyohara H; Yamada H
    Evid Based Complement Alternat Med; 2014; 2014():187036. PubMed ID: 24778699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients.
    Takayama S; Namiki T; Arita R; Ono R; Kikuchi A; Ohsawa M; Saito N; Suzuki S; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T; Hisanaga A; Mitani K; Ito T
    Front Pharmacol; 2022; 13():1008946. PubMed ID: 36438822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning-based Models for Outpatient Prescription of Kampo Formulations: An Analysis of a Health Insurance Claims Database.
    Yamana H; Okada A; Ono S; Michihata N; Jo T; Yasunaga H
    J Epidemiol; 2024 Jan; 34(1):8-15. PubMed ID: 36642513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
    Lindegårdh N; Hanpithakpong W; Wattanagoon Y; Singhasivanon P; White NJ; Day NP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):74-83. PubMed ID: 17913596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.